| "Helping women track their ovulation in a smarter way" | 
Key takeaways
-
In every cycle, a group of follicles begins developing, and normally one is selected to mature and release an egg.
-
In polyendocrine metabolic ovarian syndrome (PMOS, formerly PCOS), that selection step is disrupted, and several follicles stall at a small size instead.
-
This is called follicular arrest. The follicles are not damaged or stuck permanently.
-
It explains three things at once: the ultrasound appearance, raised anti-Müllerian hormone, and why cycle length varies so much.
-
Arrest describes what happens in a cycle, not a permanent state of the ovary.
Follicular arrest is what happens when several follicles begin developing, but none is selected to become dominant. In PMOS, the ovary recruits follicles normally, then stalls at the selection step, so multiple small follicles remain at a similar size rather than one pulling ahead. A key mechanism linking the ultrasound appearance, raised AMH, and unpredictable cycle length.
How does follicle development normally work?
Each ovary contains a large number of follicles, small fluid-filled structures, each holding an immature egg.
At the start of each cycle, a group of them begins to grow together in response to follicle-stimulating hormone (FSH). Within that group, one follicle becomes more responsive than the rest, takes the lead, and continues maturing. As it does, it suppresses the others, which stop developing and break down.1
That selected follicle is the one that eventually ruptures and releases an egg. The whole process is a competition with a single winner, and the winner determines the timing of everything that follows.
What is follicular arrest?
It is what happens when the competition never resolves.
In PMOS, the recruitment step works. A group of follicles begins developing as it should. Follicle growth and selection of a dominant follicle may be disrupted. Instead, several follicles grow to a small size and then stall there, none of them pulling ahead.1
The word “arrest” describes the stall, not damage. The follicles have not failed or died. They have stopped at a stage they would normally pass through quickly, because the signal that would push one of them forward has not resolved in anyone’s favour.
Why does this happen?
Two influences work against the selection step.
Androgen environment.
The follicles that stall are developing in a setting with more androgen activity than usual. Insulin acts alongside luteinizing hormone on the cells that produce ovarian androgens, increasing their output — the mechanism covered in our article on why “metabolic” is in the new name.1
Anti-Müllerian hormone.
Small developing follicles produce AMH, and AMH restrains how responsive follicles are to FSH.1 When many small follicles are present, more AMH is produced, and the FSH signal that would normally push one follicle into the lead has less effect. Higher AMH may further reduce follicular responsiveness to FSH, potentially contributing to impaired dominant-follicle selection.
Neither of these is a switch that is simply on or off. They are pressures, and the balance can differ from one cycle to the next in the same person — which is part of why some cycles ovulate and others do not.
Why this explains the ultrasound appearance
Because the stalled follicles are exactly what the scan shows.
When several follicles stop at a small size rather than one maturing and the rest breaking down, a larger number of small follicles are visible at the same time. That is the appearance historically described as “polycystic” — and it is why the term was misleading. These are ordinary follicles in higher-than-usual numbers, not cysts.
The 2023 International Evidence-Based Guideline sets the adult threshold for polycystic ovarian morphology at 20 or more follicles in at least one ovary (DOI: 10.1210/clinem/dgad463), counting follicles measuring 2 to 9 millimetres.2 That size range is precisely the stage at which arrest occurs.
Our article on why you don’t need ovarian cysts to have PMOS covers what this means for diagnosis.
Premom Water Based Fertility Lubricant Glycerin Free
$16.99
Why AMH is often raised
For the same reason.
AMH is produced by small developing follicles, so the amount circulating reflects roughly how many of them are present.1 More stalled follicles means more AMH.
This is why the guideline accepts an elevated AMH level as an alternative to ultrasound in adults for establishing polycystic ovarian morphology (DOI: 10.1210/clinem/dgad463). The two measurements are looking at the same thing by different routes — one counts the follicles, the other measures what they produce.
AMH is not recommended for diagnosis in adolescents, because normally developing ovaries in the years after a first period can produce similar levels.2
Why cycle length varies so much
Because a cycle has no natural end point until selection happens.
The second half of a cycle — from ovulation to a period — is comparatively consistent, because it is driven by the corpus luteum, which has a fairly predictable lifespan. The first half is where the variation lives. It lasts as long as it takes for a follicle to be selected and mature.
When selection is delayed, the first half stretches. When it does not happen at all, the cycle has no ovulation to anchor it, which is covered in our article on anovulatory cycles.
This is also why predicting a fertile window from previous cycle lengths works less well here. The variable part of the cycle is the part that determines the timing, and it varies for a reason.
What this means for tracking with Premom
Premom is an ovulation tracking application. It is not intended to diagnose, treat, cure, or prevent any disease, including PMOS. The information provided is for educational purposes and should not replace consultation with a healthcare provider.
Nothing described in this article is visible in a tracking app. Follicle counts come from an ultrasound and AMH comes from a blood test, both ordered and interpreted by a clinician.
What a record of cycle lengths across months can show is how much the first half of your cycle varies — which is an observation, not an explanation. This is true of any prediction built from cycle history, including ours, and it is why looking back after ovulation carries more information than prediction beforehand when cycles are irregular.
Log your cycle dates in the Premom app
When to talk to a clinician
The information here is general and is not a basis for self-diagnosis. Speak with a clinician if:
-
Your cycles are consistently long or vary widely from month to month
-
You have had an AMH result you do not understand
-
You have had an ultrasound report you would like explained
-
You are trying to conceive and are uncertain whether you are ovulating
Frequently asked questions
Follicular arrest describes follicles stalling at a small size rather than one being selected to mature. The word arrest refers to the stall, not to damage. What it means for you is a clinical question rather than something to infer from a mechanism.
AMH is produced by small developing follicles, so the level reflects roughly how many are present. In this condition more are present because selection stalls. It is a count by another route, and what it means for you is a question for a clinician.
No. They have stopped at a stage they would normally pass through quickly, because the signal that would push one of them into the lead has not resolved. That is a stall, not injury.
The second half of a cycle is comparatively consistent because it is driven by the corpus luteum. The first half lasts as long as it takes for a follicle to be selected and mature, so when selection is delayed, that half stretches.
The balance of influences can differ from one cycle to the next in the same person, which is part of why some cycles ovulate and others do not. What that looks like for you is a clinical question.
About PMOS
Polycystic ovary syndrome was renamed polyendocrine metabolic ovarian syndrome (PMOS) by international consensus published in The Lancet on 12 May 2026.3 A three-year transition runs to 2028, and both names remain in clinical use. Diagnostic criteria did not change, and an existing PCOS diagnosis remains valid.
In adults, diagnosis requires two of three features: clinical or biochemical hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphology on ultrasound or elevated AMH, after other causes are excluded.2 Reported prevalence varies with the criteria applied; the guideline reports 10–13% (DOI: 10.1210/clinem/dgad463).2
References
-
Strauss JF III, Barbieri RL, eds. Yen & Jaffe’s Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management. 8th ed. Elsevier; 2019. ISBN 978-0-323-47912-7.
-
Teede HJ, et al. Recommendations from the 2023 International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2023;108(10):2447–2469. DOI 10.1210/clinem/dgad463 · PMID 37580314. Recommendations 1.4.1, 1.4.4, 1.4.6.
-
Teede HJ, et al. The Lancet, 12 May 2026. DOI 10.1016/S0140-6736(26)00717-8 · PMID 42119588.
